LincRNA-BC2 (6.315±0.672, P = 0.00) and lincRNA-BC5 (2.72±0.46, P = 0.001) were consistently up-regulated more than 2-fold (mean±SD) in cancer samples. The gene discussed is CHMP2A; the disease is cancer.